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Background: Venous thromboembolism (VTE) and the subsequent development of pulmonary embolism (PE) is 
a major cause of post-operative mortality in total knee arthroplasty (TKA). We evaluated whether the addition of an 
ultrasound-guided femoral nerve block with general anesthesia affected the incidence in the development of VTE 
following TKA.
Methods: This was a retrospective non-randomized comparative study with patients assigned to groups based on the 
surgery date (pre-femoral nerve block versus post-femoral nerve block periods). All anesthesia and medical records 
of the patients who had undergone computer-navigated TKA in our facility between January 2009 and March 2010 
were retrospectively reviewed. 
Results: Forty patients were identified; 15 patients underwent computer-navigated TKA under general anesthesia 
alone (Group G) and 25 patients underwent surgery under general anesthesia combined with ultrasound-
guided femoral nerve block (Group F). The incidence of development of VTE post-operatively was significantly 
lower in Group F (P = 0.037). Logistic regression analysis identified the use of a femoral nerve block as the most 
significant variable correlating with the incidence of post-operative development of VTE, and the odds ratio for VTE 
development in Group G was 3.12 (95% CI, 0.57-20.56).
Conclusions: We suggest the possibility that the addition of a femoral nerve block on general anesthesia may reduce 
the incidence of the development of VTE following TKA. (Korean J Anesthesiol 2011; 61: 382-387)
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Introduction
Venous thromboembolism (VTE) and the subsequent 
development of pulmonary embolism (PE) is a major cause 
of post-operative mortality in total knee arthroplasty (TKA). 
Without an appropriate thromboprophylaxis, the prevalence 
rate can reach as high as 40-80% for VTE and 2-7% for PE [1]. 
Since the introduction of fondaparinux for the prevention of 
VTE in major orthopedic surgery, the risk has been significantly 
reduced to less than 15% [1,2]. However, the use of neuroaxial 
anesthesia techniques in patients who would be expected to 
receive fondaparinux is controversial [3].
Until the end of June 2009 in our facility, patients had 
undergone computer-navigated TKA under general anesthesia 
followed by intravenous fentanyl PCA (patient controlled 
anesthesia) post-operatively without the use of neuroaxial 
anesthesia techniques (including epidural and/or spinal 
anesthesia). For the prophylaxis of post-operative development 
of VTE, they routinely received fondaparinux following 24 
hours after the surgery, However, as of July 2009, we started a 
combination of single shot ultrasound-guided femoral nerve 
block on general anesthesia followed by intravenous fentanyl 
PCA post-operatively. Consequently, of the 40 patients who 
had undergone computer-navigated TKA between January 
2009 and March 2010, 15 patients underwent surgery under 
general anesthesia alone followed by intravenous fentanyl PCA 
post-operatively while 25 patients received general anesthesia 
in combination with ultrasound-guided femoral nerve block 
followed by intravenous fentanyl PCA post-operatively. Since 
we switched the anesthesia method to the combination of 
ultrasound-guided femoral nerve block on general anesthesia 
for TKA, the incidence of development of VTE has been 
significantly reduced. We report here our single institutional 
experience and suggest the possibility that a combination of 
femoral nerve block on general anesthesia may reduce the 
incidence of development of VTE following TKA.
Materials and Methods
We retrospectively reviewed anesthesia charts and medical 
records of all patients who had undergone computer-navigated 
TKA in our facility between January 2009 and March 2010. 
Forty patients were identified, among whom 15 patients 
underwent general anesthesia alone with sevoflurane, fentanyl 
and remifentanyl followed by intravenous fentanyl PCA post-
operatively (Group G). The other 25 patients underwent com-
puter-navigated TKA under general anesthesia with sevoflurane, 
fentanyl and remifentanyl in combination with a single shot 
ultrasound-guided femoral nerve block with a total amount 
of 25 ml of 0.3-0.5% ropivacaine followed by intravenous 
fentanyl PCA (Group F) [4,5]. Additionally, the patients were 
given rescue doses of ultrasound-guided femoral nerve block 
with a total amount of 25 ml of 0.3% ropivacaine at the ward 
on the first, the second, and the third post-operative day at any 
time when break through pain to intravenous fentanyl PCA was 
observed (Group F). Except for the use of ultrasound-guided 
femoral nerve block, the anesthesia methods were virtually 
identical between the two groups. In all cases, surgery was 
carried out with the tourniquet inflated and it was deflated 
precisely 2 hours after inflation. 
All patients started to receive once-daily subcutaneous 
injection of 1.5 mg of fondaparinux 24 hours after the surgery, 
together with intermittent pneumatic compression system 
(IPC) which was started immediately after surgery. As a routine 
algorithm to rule out the presence of VTE, D-dimer testing in 
combination with compression ultrasonography was carried 
out on the third and the seventh post-operative days on the 
both legs. VTE was considered positive when it was detected 
ultrasonographically, which was carried out by the skilled 
cardiovascular ultrasound technicians. 
Differences in peri-operative details among the two groups 
were analyzed using the χ
2 test for discrete variables as well 
as Kruska-Wallis and Wilcoxon rank sum tests for continuous 
variables. Logistic regression and categorical regression 
analyses were carried out on the amount of fluid infused, 
the combination of ultrasound-guided femoral nerve block, 
concomitant presence of rheumatoid arthritis and the patients’ 
ages on the incidence of post-operative VTE development. 
These variables were selected and re-examined in a retrograde 
fashion using logistic regression analysis because statistically 
significant differences were observed between the two groups 
only in these four variables. Additionally, the odds ratios of each 
factor (general anesthesia without the femoral nerve block, 
the amount of fluids infused, the concomitant presence of 
rheumatoid arthritis, and the patients’ ages) on the incidence of 
VTE development following TKA including the identification of 
95% confidence intervals (95% CI) were calculated as previously 
described elsewhere [6].
Results
Preoperative patient characteristics are summarized in 
Table 1. The patients’ ages were younger in Group F than 
those in Group G (P = 0.042). Female predominance and 
body mass index (BMI) were similar in both groups. There 
were no significant differences in the prevalence of diabetes, 
hypertension, hyperlipidemia, cardiac disease and renal 
disease requiring regular hemodialysis between the two groups 
(Table 1). There was one case of revision TKA in Group G, but 
the difference was not significant statistically. The prevalence 384 www.ekja.org
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of rheumatoid arthritis was higher in Group F (P = 0.008). 
Accordingly, the number of patients who took glucocorticoids 
as well as those classified as ASA (American Society of 
Anesthesiologists) III were higher in Group F, but the difference 
was not statistically significant. 
Peri-operative variables that may affect the incidence 
of post-operative development of VTE are summarized in 
Table 2. The duration of the operation as well as the amount 
of blood loss during the surgery were similar in both groups 
(Table 2). Presumably owing to the lower blood pressure in 
Group F, especially at the early period of surgery before the 
effect of tourniquet pain would have appeared, the amount 
of fluid infused during the surgery was larger in Group F (P 
= 0.0008). By contrast, the concentrations of D-dimer on the 
third post-operative day as well as the seventh post-operative 
day were similar between the two groups. Reflecting the higher 
prevalence of rheumatoid arthritis in Group F, C-reactive 
protein levels on the third and on the seventh post-operative 
day were slightly higher in Group F, although the differences 
were not statistically significant. 
The development of VTE was routinely evaluated in all 
patients using compression ultrasonography by skilled 
cardiovascular ultrasound technicians on the third and seventh 
post-operative days on both legs, and those diagnosed as having 
VTE were reported as such immediately. In the compression 
ultrasonography carried out on the third post-operative 
day, 7 out of 15 patients were diagnosed as having VTE 
ultrasonography in Group G, whereas only 4 out of 25 patients 
were diagnosed in Group F (significantly fewer in Group F, P = 
0.037) (Fig. 1). In the cases that developed VTE following TKA, 
all were detected in the calf region (mostly in the soleal vein) 
and no proximal type VTE was detected in the observational 
period. We immediately noticed that the incidence detected on 
the third post-operative day was quite higher than described 
previously [2]. However, we also noticed simultaneously that 
the most studies published thus far detected VTE between the 
fifth and seventh post-operative days either by the compression 
ultrasonography or contrast venography [2,7]. Interestingly, of 
the 10 cases that developed VTE on the third post-operative 
day, 5 out of 10 cases spontaneously resolved on follow-up 
observations carried out on the seventh post-operative day 
(Fig. 1) and this was precisely the incidence which we reported 
Table 1. Characteristics of Patients Preoperatively 
Measurements
General anesthesia  
alone (n = 15)
General anesthesia and femoral 
nerve block (n = 25)
Statistical 
significance
Age (yr)
Sex (M/F)
BMI (kg/m
2)
ASA (I/II/III)
Diabetes (yes/no)
Hypertension (yes/no)
Hyperlipidemia (yes/no)
Cardiac disease (yes/no)
Pre-operative antiplatelet and/or anticoagulant therapy (yes/no)
Renal disease requiring hemodialysis (yes/no)
Revision TKA/Primary TKA
Rheumatoid arthritis (yes/no)
Pre-operative glucocorticoid therapy (yes/no)
75.13 (66-84)
    4/11
25.3 (19.7-31.56)
1/13/1
    2/13
10/5
   2/13
7/8
8/7
   0/15
   1/14
   0/15
   0/15
70.28 (55-84)
   4/21
       24.95 (16.2-33.8)
0/17/8
   5/25
12/13
   5/20
   7/18
11/14
   2/23
   0/25
   9/16
   4/21
P = 0.042*
P = 0.41
†
P = 0.96*
P = 0.06
†
P = 0.59
†
P = 0.25
†
P = 0.59
†
P = 0.23
†
P = 0.57
†
P = 0.16
†
P = 0.16
†
P = 0.008
†
P = 0.103
†
Data are expressed as means (ranges) or as the number of patients. *Kruskal-Wallis and Wilcoxon rank sum tests. 
†χ
2 test. 
Table 2. Peri-operative Variables that May Affect the Incidence in Development of VTE and Post-Operative Outcomes
Measurements
General anesthesia  
alone (n = 15)
General anesthesia and femoral 
nerve block (n = 25)
Statistical 
significance
Duration of operation (min)
Intra-operative blood loss (g)
Fluid infused (ml)
D-dimer on the third post-operative day (μg/ml)
C-reactive protein on the third post-operative day (μg/ml)
D-dimer on the seventh post-operative day (μg/ml)
C-reactive protein on the seventh post-operative day (μg/ml)
188.8 (150-272)*
229.9 (45-585)*
2,627 (2,100-3,300)*
5.23 (2.3-12.4)*
12.76 (4.8-22.4)*
10.17 (3.5-19.4)*
4.2 (0.5-10.8)*
179.5 (130-233)*
171.4 (50-385)*
3,162 (1,300-4,000)*
4.78 (2.1-7.8)*
15.93 (7.2-26.4)*
8.83 (5.4-16.1)*
4.44 (1.7-10.8)*
P = 0.51
†
P = 0.16
†
P = 0.0008
†
P = 0.92
†
P = 0.067
†
P = 0.42
†
P = 0.78
†
*Data values are expressed as means (ranges). 
†Kruskal-Wallis and Wilcoxon rank sum tests.385 www.ekja.org
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previously [4]. Since the once-daily subcutaneous injection of 
fondaparinux had been continued as the initial treatment of 
VTE, our results support the efficacy of fondaparinux not only 
in the prevention of, but also in the initial treatment of VTE 
[8]. Our results also suggest the possibility that the incidence 
of VTE development following TKA has been underestimated 
even with the use of fondaparinux, although the dose of 
fondaparinux we selected is smaller that the standard dose used 
in the United States and European countries. 
To further elucidate what variable(s) most strongly correlated 
with the incidence of VTE development following TKA post-
operatively, we conducted logistic regression analysis on the 
amount of fluid infused and a categorical regression analysis 
on the use of a femoral nerve block, the ages of patients and 
the concomitant presence of rheumatoid arthritis. These 
analyses identified the combination of femoral nerve block on 
general anesthesia as the most significant variable that strongly 
correlated with the prevention of VTE development (P = 0.0426); 
however, the amount of fluid infused (P = 0.26), the patients’ 
ages (P = 0.297) and the concomitant presence of rheumatoid 
arthritis (P = 0.908) had no effect (Table 3). The calculated 
odds ratio of general anesthesia alone as compared to the 
combination of femoral nerve block on the development of VTE 
was 3.12 (95% CI, 0.57-20.56), followed by the amount of fluid 
infused (2.19: 95% CI, 0.03-79.98), without the concomitant 
presence of rheumatoid arthritis (1.72; 95%CI, 0.18-38.52) and 
the patients’ ages (0.53; 95% CI, 0.02-15.67) (Table 3).
Discussion
Several crucial factors that may affect the incidence of 
VTE following TKA have been identified thus far, such as the 
duration of the surgery [9], the use of anticoagulant drugs [10], 
the use of tourniquet [11] and the use of IPCs [12]. We have 
shown here that the addition of ultrasound-guided femoral 
nerve block on general anesthesia may reduce the incidence of 
development of VTE following TKA.
Similarly, the use of epidural anesthesia during surgery 
had been previously reported to reduce the incidence of VTE 
following TKA, presumably owing to the increased blood flow of 
lower extremities by the effect of sympathectomy [13]. However, 
this was not the case with the ultrasound-guided femoral 
nerve block because it is not expected to provide the sufficient 
level of sympathectomy unless it was performed at the psoas 
compartment level [14]. Although the precise mechanisms by 
which the combination of ultrasound-guided femoral nerve 
block reduced the incidence of VTE following TKA remain to 
be elucidated, we speculate that with virtually zero pain post-
operatively due to excellent analgesic effects of the femoral 
nerve block on TKA, early mobilization with the assistance of 
physiotherapists (as early as the first post-operative day) could 
have prevented the development of VTE in our facility. Although 
early mobilization with the assistance of a physiotherapist was 
initiated on the first post-operative day in both groups, it was 
refused by many patients in Group G because of intense pain 
during activity, which was not the case for patients in Group F. 
The significance of our report is that the addition of a femoral 
nerve block on general anesthesia had reduced the incidence of 
Fig. 1. Number of patients who developed VTE (black bar) and the 
patients who did not develop VTE (white bar) on the third post-
operative day (POD3) and on the seventh post-operative day (POD7) 
are shown. The incidence in development of VTE is significantly 
lower in Group F. Note that half the cases that developed VTE 
on the third post-operative day spontaneously resolved as the 
administration of fondaparinux was continued. 
Table 3. Logistic Regression and Categorical Regression Analyses on the Incidence of Development of VTE
Measurements Statistical significance Odds ratios 95% CI
The combination of ultrasound-guided femoral nerve block
The amount of fluids infused
Without the concomitant presence of rheumatoid arthritis
The patients’ ages
P = 0.0426*
P = 0.26
†
P = 0.908
†
P = 0.297*
3.12
‡
2.19
1.72
§
0.53
0.57-20.56
0.03-79.98
0.18-38.52
0.02-15.67
*The categorical regression analysis. 
†Logistic regression analysis. 
‡Calculated as, general anesthesia alone/the combination of ultrasound-
guided femoral nerve. 
§Calculated as, without the concomitant presence of rheumatoid arthritis/the concomitant presence of rheumatoid 
arthritis.386 www.ekja.org
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development of VTE following TKA even under the routine use 
of anticoagulants. By contrast, the use of epidural anesthesia 
for the management of TKA similarly reduced the incidence of 
post-operative development of VTE. However, the advantage 
of epidural anesthesia is limited to when anticoagulants can 
not be used for prophylaxis. This suggests that the impact 
of the use of anticoagulants as prophylactic therapy for VTE 
surpasses the benefits of regional anesthesia with respect to 
the reduction of the incidence of VTE development following 
TKA [15]. Owing to the relatively small number of patients in 
our study, there is a possibility of a false positive conclusion. 
However, the use of femoral nerve block both intra- and post-
operatively was particularly efficacious in eliminating pain 
during activity early in the post-operative period. This conferred 
superiority to opioid-based general anesthesia alone and/
or in combination with epidural anesthesia, where both were 
efficacious in eliminating the pain at rest, but not sufficient for 
pain during activity. Hence, the combination of femoral nerve 
block might have facilitated early mobilization of the patients 
with the assistance of a physiotherapist more efficaciously than 
general anesthesia alone and/or the combination of epidural 
anesthesia.
During the analysis, we noticed that the incidence in the 
development of VTE in Group G was quite higher than those 
reported previously, provided that we had used fondaparinux 
for the prevention of development of VTE [12]. In addition, the 
prophylactic effect of fondaparinux in the early post-operative 
period might have been the same as those in the late post-
operative period. However, this fails to account for the reason 
why subclinical VTE developed in the early post-operative 
period and spontaneously resolved at the 7
th post-operative 
day. We searched database for kinetic analysis on the incidence 
and timing of VTE after TKA in recent years, particularly under 
anticoagulation therapy post-operatively and the studies are 
very limited. One such large scale retrospective study published 
in 2009 [16] indentified the second post-operative day as the day 
where PE (pulmonary embolism) developed most frequently, 
followed by the first and the third post-operative days. Hence, 
we speculate that the incidence of development of VTE is 
usually most frequently seen in the early post-operative period 
and decreases thereafter, partly owing to the prophylactic effect 
of fondaparinux in the further development of VTE. In addition, 
thrombolysis might have taken place in the presence of 
fondaparinux, which was the primary reason why fondaparinux 
was recommended as the choice for initial treatment of VTE [8]. 
Still, the subclinical incidence of VTE in our facility 
was higher than those reported previously. One possible 
explanation for the discrepancy we observed was the dose of 
fondaparinux we have selected. The standard recommended 
dose of fondaparinux in European countries and in the United 
States is once-daily subcutaneous injection of 2.5 mg after major 
orthopedic surgery [17]. However, we have observed a case with 
serious gastrointestinal bleeding when 2.5 mg of fondaparinux 
was used. In this regard, 1.5 mg of fondaparinux can be more 
safely used in Asian populations without safety issues with the 
similar efficacy, especially for aged female patients (Asakura Y, 
Takagi H, unpublished observations).
During the observational period, all VTE cases detected in 
our facility developed in the calf region and there were no cases 
that developed PE following VTE. Although the proximal type 
of VTE is an established cause of pulmonary embolism, there 
still is controversy regarding the significance of calf vein VTE in 
the subsequent development of PE. Wang et al. [18] previously 
reported the precise outcome of VTE cases in the calf region 
following TKA. They reported 48 cases (44 for calf VTE and 4 
for popliteal VTE) and only a half (24 cases) were symptomatic. 
They also reported that no single case developed PE following 
VTE. However, in some cases, PE may certainly take place even 
after the development of calf type VTE [19,20]. Therefore, it is 
obvious that even “subclinical” calf type VTE may develop PE 
without an appropriate thromboprophylaxis. 
It was somewhat surprising that the incidence of VTE was 
significantly lower in Group F, despite the fact that the group 
consisted of the significantly larger number of patients with 
rheumatoid arthritis, because it was previously considered to 
be one of the risk factors for VTE [21]. Our present observations 
suggest that the multimodal approach to reduce the incidence 
of VTE which included: complete pain control that enables 
the early mobilization of the patients with the assistance of 
physiotherapists, the use of fondaparinux, and the use of 
IPCs immediately after the surgery, could have reduced the 
incidence in the development of VTE even in the presence of a 
single risk factor.
Finally, the limitations of the interpretation of our results are 
as follows; 
1)    This was a retrospective comparative study and the 
background of the patients differs with respect to the 
following categories; the concomitant presence of 
rheumatoid arthritis, age and the amount of fluid infused 
during the surgery. Nonetheless, we were able to identify 
the use of the femoral nerve as the most significant 
variable for the prevention of VTE.
2)    The number of the patients was relatively small. However, 
we would like to address the fact that we are unable to 
conduct a prospective randomized controlled trial owing 
to the ethical concerns (i.e. fatal outcomes from the 
development of PE).
In conclusion, we suggest the possibility that addition 
of a femoral nerve block on general anesthesia reduced the 
incidence in the development of VTE following TKA.387 www.ekja.org
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